Company Valuation: Takeda Pharmaceutical Company Limited

Data adjusted to current consolidation scope
Fiscal Period: March 2022 2023 2024 2025 2026 2027 2028 2029
Market Cap 1 5,423,454 6,762,204 6,564,378 6,749,675 8,948,061 11,071,918 - -
Change - 24.68% -2.93% 2.82% 32.57% 23.74% - -
Enterprise Value (EV) 1 8,919,170 10,611,015 10,950,330 10,725,175 5,130,461 15,025,490 14,788,249 14,447,461
Change - 18.97% 3.2% -2.06% -52.16% 192.87% -1.58% -2.3%
P/E 23.8x 21.3x 45.4x 64.6x 46.4x 49.6x 34x 27.7x
PBR 0.95x 1.06x 0.9x 1x 1.2x 1.49x 1.49x 1.48x
PEG - 0.5x -0.8x -2.5x 0.6x 3.4x 0.7x 1.2x
Capitalization / Revenue 1.52x 1.68x 1.54x 1.47x 1.99x 2.35x 2.29x 2.23x
EV / Revenue 2.5x 2.63x 2.57x 2.34x 1.14x 3.18x 3.06x 2.9x
EV / EBITDA 8.54x 9.19x 11.6x 9.71x 4.54x 12.3x 11.1x 10.4x
EV / EBIT 19.4x 21.6x 51.1x 31.3x 12.6x 32x 23.5x 19.8x
EV / FCF 8.92x 28.7x 43.4x 15.5x 8.14x 26.9x 20.1x 18.6x
FCF Yield 11.2% 3.49% 2.31% 6.43% 12.3% 3.72% 4.97% 5.38%
Dividend per Share 2 180 180 188 196 200 204.3 208.4 214.9
Rate of return 5.15% 4.14% 4.49% 4.44% 3.53% 2.95% 3.01% 3.1%
EPS 2 147.1 204.3 92.09 68.36 122 139.7 204.1 249.9
Distribution rate 122% 88.1% 204% 287% 164% 146% 102% 86%
Net sales 1 3,569,006 4,027,478 4,263,762 4,581,600 4,505,700 4,721,475 4,836,711 4,973,426
EBITDA 1 1,043,995 1,154,905 942,077 1,103,982 1,129,888 1,216,836 1,328,786 1,392,731
EBIT 1 460,844 490,505 214,100 342,600 408,800 469,822 629,207 728,116
Net income 1 230,059 317,017 144,067 107,900 191,800 211,509 343,306 411,949
Net Debt 1 3,495,716 3,848,811 4,385,952 3,975,500 -3,817,600 3,953,572 3,716,331 3,375,543
Reference price 2 3,498.00 4,350.00 4,184.00 4,413.00 5,664.00 6,931.00 6,931.00 6,931.00
Nbr of stocks (in thousands) 1,550,444 1,554,530 1,568,924 1,529,498 1,579,813 1,597,449 - -
Announcement Date 5/11/22 5/11/23 5/9/24 5/8/25 5/13/26 - - -
1JPY in Million2JPY
Estimates

P/E, Detailed evolution



P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
49.77x3.19x12.6x2.95% 69.43B
41.9x14.18x30.07x0.48% 1,275B
41.35x6.94x19.51x1.89% 680B
37.55x8.61x17.78x2.34% 521B
22x5.33x13.34x2.45% 389B
102.54x5.86x24.97x2.35% 356B
24.41x5.87x14.28x2.7% 305B
24.28x4.86x13.64x1.8% 287B
23.87x7.33x13.47x2.18% 250B
-39.41x7.29x45.94x1.97% 208B
Average 32.83x 6.95x 20.56x 2.11% 434B
Weighted average by Cap. 37.28x 8.80x 22.35x 1.71%

Y-o-Y evolution of P/E

Valuation ratios - P/E - Takeda Pharmaceutical Company Limited

Historical PBR trend

Valuation ratios - PBR - Takeda Pharmaceutical Company Limited

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - Takeda Pharmaceutical Company Limited

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - Takeda Pharmaceutical Company Limited


Year-on-year evolution of the Yield

Valuation ratios - Yield - Takeda Pharmaceutical Company Limited
  1. Stock Market
  2. Stocks
  3. 4502 Stock
  4. Valuation Takeda Pharmaceutical Company Limited